Plethico Pharmaceuticals Ltd. - Research Center

---

Results

• Quarterly
• Half yearly
• Annual

Statement

• Balance sheet
• P&L
• Cash flow

More

• Dividend
• Bonus
• Share holding
• Capital structures
• Ratio

Mar ' 15	Mar ' 14	Dec ' 12	Dec ' 11	Dec ' 10

Sources of funds

Owner's fund

Equity share capital

34.07

34.07

34.07

34.07

34.07

Share application money

-

-

-

20.00

-

Preference share capital

-

-

-

-

-

Reserves & surplus

224.97

504.56

513.29

611.03

665.17

Loan funds

Secured loans

341.15

214.04

235.99

220.76

155.75

Unsecured loans

-

49.94

113.16

673.43

425.31

Total

600.18

802.60

896.51

1,559.29

1,280.30

Uses of funds

Fixed assets

Gross block

100.29

194.28

193.53

190.19

185.61

Less : revaluation reserve

-

-

-

-

-

Less : accumulated depreciation

-

75.65

65.31

57.31

49.36

Net block

100.29

118.63

128.21

132.87

136.25

Capital work-in-progress

-

-

-

-

3.08

Investments

487.00

806.56

806.56

806.56

775.57

Net current assets

Current assets, loans & advances

943.63

778.34

769.42

695.35

433.37

Less : current liabilities & provisions

930.73

900.93

807.69

75.99

69.45

Total net current assets

12.90

-122.59

-38.27

619.36

363.93

Miscellaneous expenses not written

-

-

-

0.50

1.47

Total

600.18

802.60

896.51

1,559.29

1,280.30

Notes:

Book value of unquoted investments

-

806.56

198.96

806.56

775.57

Market value of quoted investments

-

-

-

-

-

Contingent liabilities

-

152.04

234.37

215.38

12.71

Number of equity sharesoutstanding (Lacs)

340.67

340.67

340.67

340.67

340.67